US

Miracor Medical fetches Series D funding

Miracor Medical, a European medical device firm, has raised 30 million euros in Series D funding. Ming Capital led the round.

Evox Therapeutics procures $45.4 mln Series B

UK-based Evox Therapeutics Ltd, an exosome therapeutics company, has raised $45.4 million in Series B financing. Redmile Group led the round with participation from other investors that included GV, Cowen Healthcare Investments, Panacea Healthcare Venture, Borealis Ventures, Oxford Sciences Innovation and Oxford University.

Otsuka completes Visterra acquisition for about $430 mln

Otsuka has closed its previously announced acquisition of Visterra, a developer of antibody-based therapies for the treatment of patients with kidney diseases and other hard-to-treat diseases, for about $430 million in cash. Visterra's backers included Polaris Partners, Flagship Pioneering, the Bill and Melinda Gates Foundation, MRL Ventures Fund, Vertex Ventures HC, Temasek Holdings, Lux Capital, Alleghany Financial Group Ventures, CTI Life Sciences Fund and Alexandria Equities.

VC-backed Tempest Therapeutics recruits Laport as chief medical officer

Tempest Therapeutics Inc, a biotech company, has named Dr. Ginna Laport as chief medical officer. Previously, she was vice president of clinical development at Corvus Pharmaceuticals. Also, Tempest has promoted Dr. Alicia Levey to chief business officer. Tempest’s backers include Versant Ventures, F-Prime Capital, Quan Capital, Lilly Asia Ventures, Foresite Capital and Eight Roads Ventures.

Avid Ratings inks $6 mln

Madison, Wisconsin-based Avid Ratings, a customer experience company for homebuilders, has secured $6 million in funding. The investors were 4490 Ventures and Beringea.

Offensive Security lands funding

Offensive Security, a provider of online penetration testing training and certification, has secured an undisclosed amount of funding. Spectrum Equity led the round with participation from TenEleven Ventures.

Atlassian to buy OpsGenie for $295 mln

Atlassian has agreed to acquire OpsGenie, which is backed by Battery Ventures, for $295 million. Based in Boston, OpsGenie is a provider of alerting and on-call management solutions for development and operations teams.

Jianke snags $130 mln Series B

Jianke, a Chinese online B2C pharmacy and healthcare services platform, has raised $130 million in Series B funding. GTJA Investment Group led the round with participation from HBM Healthcare Investments and Crescent Point.

More departures at Social Capital

Social Capital, founded in 2011 by early Facebook executive Chamath Palihapitiya, has seen more departures. Most recently, Partner Mike Ghaffary, who joined a year ago, announced last week he was leaving to focus on angel investing. In addition, Ashley Mayer, a partner and VP of marketing who joined in 2015 from Box, tweeted she has also left to pursue new adventures.

Phrasee raises $4 mln from Albion Capital Group, Next Fifteen, Galvanise Capital

Phrasee said it raised $4 million of Series A capital in a round led by Albion Capital Group and joined by existing investors Next Fifteen and Galvanise Capital.